Related Experiment Video

Updated: Aug 18, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

Quiz page. Posttransplantation lymphoproliferative disorder (PTLD) involving the brain and the allograft

Sydney Tang1, Kar Neng Lai

  • 1Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|April 5, 2005
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

Related Experiment Videos

Last Updated: Aug 18, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...

Articles linked to this work by shared authors, journal, and citation graph.

Translocator Protein and Mitochondrial Dysfunction in Chronic Kidney Disease​.

Journal of the American Society of Nephrology : JASN·2026

C5a/C5aR1 mediates AKI-CKD transition by enhancing autophagy.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026

Add-on astragalus in type 2 diabetes and chronic kidney disease: A multi-center, assessor-blind, randomized controlled trial.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2024

Add-on Rehmannia-6-Based Chinese Medicine in Type 2 Diabetes and CKD: A Multicenter Randomized Controlled Trial.

Clinical journal of the American Society of Nephrology : CJASN·2023

Tubulovascular protection from protease-activated receptor-1 depletion during AKI-to-CKD transition.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2023

The long noncoding RNA Meg3 mediates TLR4-induced inflammation in experimental obstructive nephropathy.

Clinical science (London, England : 1979)·2023

Membranoproliferative Glomerulonephritis Susceptibility Loci: A Genome-Wide Association Study.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

Association of Estimated GFR at the Time of Peritoneal Dialysis Catheter Insertion With Dialysis-Related Complications.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

Depressive Symptoms and Incident Peripheral Arterial Disease Among Adults With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

Outcomes Following Kidney Failure From IgA Nephropathy Compared to Diabetic Kidney Disease and Other Glomerular Diseases.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

KDOQI Commentary on the 2025 AHA/ACC Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

Initiation of Apixaban Versus Warfarin in Patients With Kidney Failure on Hemodialysis With Newly Diagnosed Atrial Fibrillation: A Target Trial Emulation.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

Beyond Histocompatibility: Donor Tissue Immune States and Their Role in Heart Transplantation.

International journal of molecular sciences·2026

Takotsubo Syndrome in Solid Organ Transplant Recipients: Current Evidence, Clinical Challenges, and Future Perspectives-A Narrative Review.

Journal of clinical medicine·2026

Postpartum Triple Allograft Injury with Atypical Hemolytic Uremic Syndrome, Recurrent IgA Nephropathy, and Antibody-Mediated Rejection in a Kidney Retransplant Recipient: A Case Report.

Journal of clinical medicine·2026

Combination of Serum Leucine-rich Alpha-2-Glycoprotein 1 and Citrulline as Biomarkers of Graft Monitoring and Response to Antirejection Treatment in Intestinal Transplantation.

Transplantation·2026

Donor-Derived Fc Gamma Receptor Polymorphisms and Infectious Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation.

Transplantation proceedings·2026

MIF inhibitor ISO-1 attenuates ischemia-reperfusion injury in a rat model of donation after circulatory death liver transplantation.

PloS one·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us